申请人:HOFFMANN-LA ROCHE INC.
公开号:US20150218133A1
公开(公告)日:2015-08-06
The invention is concerned with the compounds of formula (I)
and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds of formula (I) can be used as medicament.
本发明涉及式(I)化合物及其药学上可接受的盐。此外,本发明还涉及制造和使用式(I)化合物的方法,以及含有这种化合物的药物组合物。式(I)化合物可用作药物。